EUVIMEDEUVIMED entdecken
Crossref

Novel Radiotheranostic Ligands Targeting Prostate-Specific Membrane Antigen Based on Dual Linker Approach

Nobuki Kazuta, Kazuma Nakashima iD, Yuta Tarumizu, Takumi Sato, Yoshifumi Maya, Hiroyuki Watanabe iD, Masahiro Ono iD

Molecular Pharmaceutics · 06.01.2025 · 22 (1) · 377-386

DOI: 10.1021/acs.molpharmaceut.4c00974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 30.11.2024. Verfasst von Nobuki Kazuta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan. Hauptthemen laut MEDLINE: Glutamate Carboxypeptidase II, Prostatic Neoplasms, Antigens, Surface, Radiopharmaceuticals. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Support for Pioneering Research Initiated by the Next Generation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotheranostics using prostate-specific membrane antigen (PSMA)-targeting radioligands offers precision medicine by performing radionuclide therapy based on results of diagnosis. Albumin binder (ALB) binds to albumin reversibly and contributes to effective radiotheranostics by enhancing tumor accumulation of PSMA-targeting radioligands. We newly developed two ALB-containing PSMA-targeting radioligands including dual functional linkers, a hydrophilic linker, d-glutamic acid, and a hydrophobic linker, 4-(aminomethyl)benzoic acid, with the opposite arrangement (PNT-DA6 and PNT-DA7). A biodistribution study of [111In]In-PNT-DA6 indicated that the introduction and arrangement of dual functional linkers contributed to improved pharmacokinetics. A single photon emission computed tomography study of [111In]In-PNT-DA6 produced a clear PSMA-expressing tumor image. Moreover, [225Ac]Ac-PNT-DA6 showed the inhibition of tumor growth in targeted radionuclide therapy in PSMA-expressing tumor-bearing mice. These results indicated that [111In]In-PNT-DA6 and [225Ac]Ac-PNT-DA6 exhibited useful characteristics as PSMA-targeting radiotheranostic ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutamate Carboxypeptidase IIProstatic NeoplasmsAntigens, SurfaceRadiopharmaceuticalsAnimalsMiceMaleLigandsHumansTissue DistributionCell Line, TumorIndium RadioisotopesTomography, Emission-Computed, Single-PhotonMice, NudeXenograft Model Antitumor AssaysAlbumins

Stichwörter der Autor:innen

4-(aminomethyl)benzoic acidalbumin binderd-glutamic aciddual functional linkersprostate-specific membrane antigenradiotheranostics

Substanzen

LigandsGlutamate Carboxypeptidase IIAntigens, SurfaceRadiopharmaceuticalsFOLH1 protein, humanIndium RadioisotopesAlbuminsIndium-111

Autor:innen und Institutionen

  • Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
  • Research Center, Nihon Medi-Physics Co., Ltd., 3-1 Kitasode, Sodegaura-shi, Chiba 299-0266, Japan.

ORCID-Profile: Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono

Förderung

  • Japan Agency for Medical Research and Development
  • Support for Pioneering Research Initiated by the Next Generation

Zitieren

APA

Kazuta, N., Nakashima, K., Tarumizu, Y., Sato, T., Maya, Y., Watanabe, H., & Ono, M. (2025). Novel Radiotheranostic Ligands Targeting Prostate-Specific Membrane Antigen Based on Dual Linker Approach. Molecular Pharmaceutics, 22(1), 377-386. https://doi.org/10.1021/acs.molpharmaceut.4c00974

Vancouver

Kazuta N, Nakashima K, Tarumizu Y, Sato T, Maya Y, Watanabe H, et al. Novel Radiotheranostic Ligands Targeting Prostate-Specific Membrane Antigen Based on Dual Linker Approach. Molecular Pharmaceutics. 2025;22(1):377-386. doi:10.1021/acs.molpharmaceut.4c00974

BibTeX
@article{Kazuta2025,
  author = {Kazuta, Nobuki and Nakashima, Kazuma and Tarumizu, Yuta and Sato, Takumi and Maya, Yoshifumi and Watanabe, Hiroyuki and Ono, Masahiro},
  title = {Novel Radiotheranostic Ligands Targeting Prostate-Specific Membrane Antigen Based on Dual Linker Approach},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {1},
  pages = {377--386},
  doi = {10.1021/acs.molpharmaceut.4c00974}
}
Kostenlos starten →